Global Surgical Skin Antiseptic Market Research Report 2024
Antiseptics are chemical agents that slow or stop the growth of micro-organisms on external body surfaces, helping prevent infections.
According to Mr Accuracy reports new survey, global Surgical Skin Antiseptic market is projected to reach US$ 1053.3 million in 2029, increasing from US$ 827.4 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Surgical Skin Antiseptic market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Surgical Skin Antiseptic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
3M
BD
EcoLab
Medtronic
Cardinal Health
Schülke & Mayr GmbH
Purdue Pharma
CVS Health
B. Braun Melsungen
McKesson Corp
Stryker
PSK Pharma
Mölnlycke
MPM Medical
Vesismin Health
AmerisourceBergen
Cigna
Medline Industries
Abbott
Baxter
Sirmaxo Chemicals
Kimberly-Clark
Microgen
Segment by Type
Alcohols
Chlorhexidine
Iodine
Octenidine
Others
Segment by Application
Surgeries
Injections
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Surgical Skin Antiseptic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content
1 Surgical Skin Antiseptic Market Overview
1.1 Product Overview and Scope of Surgical Skin Antiseptic
1.2 Surgical Skin Antiseptic Segment by Type
1.2.1 Global Surgical Skin Antiseptic Market Value Comparison by Type (2024-2034)
1.2.2 Alcohols
1.2.3 Chlorhexidine
1.2.4 Iodine
1.2.5 Octenidine
1.2.6 Others
1.3 Surgical Skin Antiseptic Segment by Application
1.3.1 Global Surgical Skin Antiseptic Market Value by Application: (2024-2034)
1.3.2 Surgeries
1.3.3 Injections
1.3.4 Others
1.4 Global Surgical Skin Antiseptic Market Size Estimates and Forecasts
1.4.1 Global Surgical Skin Antiseptic Revenue 2018-2029
1.4.2 Global Surgical Skin Antiseptic Sales 2018-2029
1.4.3 Global Surgical Skin Antiseptic Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Surgical Skin Antiseptic Market Competition by Manufacturers
2.1 Global Surgical Skin Antiseptic Sales Market Share by Manufacturers (2018-2024)
2.2 Global Surgical Skin Antiseptic Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Surgical Skin Antiseptic Average Price by Manufacturers (2018-2024)
2.4 Global Surgical Skin Antiseptic Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Surgical Skin Antiseptic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Surgical Skin Antiseptic, Product Type & Application
2.7 Surgical Skin Antiseptic Market Competitive Situation and Trends
2.7.1 Surgical Skin Antiseptic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Surgical Skin Antiseptic Players Market Share by Revenue
2.7.3 Global Surgical Skin Antiseptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Surgical Skin Antiseptic Retrospective Market Scenario by Region
3.1 Global Surgical Skin Antiseptic Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Surgical Skin Antiseptic Global Surgical Skin Antiseptic Sales by Region: 2018-2029
3.2.1 Global Surgical Skin Antiseptic Sales by Region: 2018-2024
3.2.2 Global Surgical Skin Antiseptic Sales by Region: 2024-2029
3.3 Global Surgical Skin Antiseptic Global Surgical Skin Antiseptic Revenue by Region: 2018-2029
3.3.1 Global Surgical Skin Antiseptic Revenue by Region: 2018-2024
3.3.2 Global Surgical Skin Antiseptic Revenue by Region: 2024-2029
3.4 North America Surgical Skin Antiseptic Market Facts & Figures by Country
3.4.1 North America Surgical Skin Antiseptic Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Surgical Skin Antiseptic Sales by Country (2018-2029)
3.4.3 North America Surgical Skin Antiseptic Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Surgical Skin Antiseptic Market Facts & Figures by Country
3.5.1 Europe Surgical Skin Antiseptic Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Surgical Skin Antiseptic Sales by Country (2018-2029)
3.5.3 Europe Surgical Skin Antiseptic Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Surgical Skin Antiseptic Market Facts & Figures by Country
3.6.1 Asia Pacific Surgical Skin Antiseptic Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Surgical Skin Antiseptic Sales by Country (2018-2029)
3.6.3 Asia Pacific Surgical Skin Antiseptic Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Surgical Skin Antiseptic Market Facts & Figures by Country
3.7.1 Latin America Surgical Skin Antiseptic Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Surgical Skin Antiseptic Sales by Country (2018-2029)
3.7.3 Latin America Surgical Skin Antiseptic Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Surgical Skin Antiseptic Market Facts & Figures by Country
3.8.1 Middle East and Africa Surgical Skin Antiseptic Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Surgical Skin Antiseptic Sales by Country (2018-2029)
3.8.3 Middle East and Africa Surgical Skin Antiseptic Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Surgical Skin Antiseptic Sales by Type (2018-2029)
4.1.1 Global Surgical Skin Antiseptic Sales by Type (2018-2024)
4.1.2 Global Surgical Skin Antiseptic Sales by Type (2024-2029)
4.1.3 Global Surgical Skin Antiseptic Sales Market Share by Type (2018-2029)
4.2 Global Surgical Skin Antiseptic Revenue by Type (2018-2029)
4.2.1 Global Surgical Skin Antiseptic Revenue by Type (2018-2024)
4.2.2 Global Surgical Skin Antiseptic Revenue by Type (2024-2029)
4.2.3 Global Surgical Skin Antiseptic Revenue Market Share by Type (2018-2029)
4.3 Global Surgical Skin Antiseptic Price by Type (2018-2029)
5 Segment by Application
5.1 Global Surgical Skin Antiseptic Sales by Application (2018-2029)
5.1.1 Global Surgical Skin Antiseptic Sales by Application (2018-2024)
5.1.2 Global Surgical Skin Antiseptic Sales by Application (2024-2029)
5.1.3 Global Surgical Skin Antiseptic Sales Market Share by Application (2018-2029)
5.2 Global Surgical Skin Antiseptic Revenue by Application (2018-2029)
5.2.1 Global Surgical Skin Antiseptic Revenue by Application (2018-2024)
5.2.2 Global Surgical Skin Antiseptic Revenue by Application (2024-2029)
5.2.3 Global Surgical Skin Antiseptic Revenue Market Share by Application (2018-2029)
5.3 Global Surgical Skin Antiseptic Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.1.4 3M Surgical Skin Antiseptic Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.2.4 BD Surgical Skin Antiseptic Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 EcoLab
6.3.1 EcoLab Corporation Information
6.3.2 EcoLab Description and Business Overview
6.3.3 EcoLab Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.3.4 EcoLab Surgical Skin Antiseptic Product Portfolio
6.3.5 EcoLab Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Medtronic Surgical Skin Antiseptic Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Cardinal Health
6.5.1 Cardinal Health Corporation Information
6.5.2 Cardinal Health Description and Business Overview
6.5.3 Cardinal Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Cardinal Health Surgical Skin Antiseptic Product Portfolio
6.5.5 Cardinal Health Recent Developments/Updates
6.6 Schülke & Mayr GmbH
6.6.1 Schülke & Mayr GmbH Corporation Information
6.6.2 Schülke & Mayr GmbH Description and Business Overview
6.6.3 Schülke & Mayr GmbH Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Schülke & Mayr GmbH Surgical Skin Antiseptic Product Portfolio
6.6.5 Schülke & Mayr GmbH Recent Developments/Updates
6.7 Purdue Pharma
6.6.1 Purdue Pharma Corporation Information
6.6.2 Purdue Pharma Description and Business Overview
6.6.3 Purdue Pharma Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Purdue Pharma Surgical Skin Antiseptic Product Portfolio
6.7.5 Purdue Pharma Recent Developments/Updates
6.8 CVS Health
6.8.1 CVS Health Corporation Information
6.8.2 CVS Health Description and Business Overview
6.8.3 CVS Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.8.4 CVS Health Surgical Skin Antiseptic Product Portfolio
6.8.5 CVS Health Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Corporation Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.9.4 B. Braun Melsungen Surgical Skin Antiseptic Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 McKesson Corp
6.10.1 McKesson Corp Corporation Information
6.10.2 McKesson Corp Description and Business Overview
6.10.3 McKesson Corp Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.10.4 McKesson Corp Surgical Skin Antiseptic Product Portfolio
6.10.5 McKesson Corp Recent Developments/Updates
6.11 Stryker
6.11.1 Stryker Corporation Information
6.11.2 Stryker Surgical Skin Antiseptic Description and Business Overview
6.11.3 Stryker Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Stryker Surgical Skin Antiseptic Product Portfolio
6.11.5 Stryker Recent Developments/Updates
6.12 PSK Pharma
6.12.1 PSK Pharma Corporation Information
6.12.2 PSK Pharma Surgical Skin Antiseptic Description and Business Overview
6.12.3 PSK Pharma Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.12.4 PSK Pharma Surgical Skin Antiseptic Product Portfolio
6.12.5 PSK Pharma Recent Developments/Updates
6.13 Mölnlycke
6.13.1 Mölnlycke Corporation Information
6.13.2 Mölnlycke Surgical Skin Antiseptic Description and Business Overview
6.13.3 Mölnlycke Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Mölnlycke Surgical Skin Antiseptic Product Portfolio
6.13.5 Mölnlycke Recent Developments/Updates
6.14 MPM Medical
6.14.1 MPM Medical Corporation Information
6.14.2 MPM Medical Surgical Skin Antiseptic Description and Business Overview
6.14.3 MPM Medical Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.14.4 MPM Medical Surgical Skin Antiseptic Product Portfolio
6.14.5 MPM Medical Recent Developments/Updates
6.15 Vesismin Health
6.15.1 Vesismin Health Corporation Information
6.15.2 Vesismin Health Surgical Skin Antiseptic Description and Business Overview
6.15.3 Vesismin Health Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Vesismin Health Surgical Skin Antiseptic Product Portfolio
6.15.5 Vesismin Health Recent Developments/Updates
6.16 AmerisourceBergen
6.16.1 AmerisourceBergen Corporation Information
6.16.2 AmerisourceBergen Surgical Skin Antiseptic Description and Business Overview
6.16.3 AmerisourceBergen Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.16.4 AmerisourceBergen Surgical Skin Antiseptic Product Portfolio
6.16.5 AmerisourceBergen Recent Developments/Updates
6.17 Cigna
6.17.1 Cigna Corporation Information
6.17.2 Cigna Surgical Skin Antiseptic Description and Business Overview
6.17.3 Cigna Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Cigna Surgical Skin Antiseptic Product Portfolio
6.17.5 Cigna Recent Developments/Updates
6.18 Medline Industries
6.18.1 Medline Industries Corporation Information
6.18.2 Medline Industries Surgical Skin Antiseptic Description and Business Overview
6.18.3 Medline Industries Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Medline Industries Surgical Skin Antiseptic Product Portfolio
6.18.5 Medline Industries Recent Developments/Updates
6.19 Abbott
6.19.1 Abbott Corporation Information
6.19.2 Abbott Surgical Skin Antiseptic Description and Business Overview
6.19.3 Abbott Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Abbott Surgical Skin Antiseptic Product Portfolio
6.19.5 Abbott Recent Developments/Updates
6.20 Baxter
6.20.1 Baxter Corporation Information
6.20.2 Baxter Surgical Skin Antiseptic Description and Business Overview
6.20.3 Baxter Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Baxter Surgical Skin Antiseptic Product Portfolio
6.20.5 Baxter Recent Developments/Updates
6.21 Sirmaxo Chemicals
6.21.1 Sirmaxo Chemicals Corporation Information
6.21.2 Sirmaxo Chemicals Surgical Skin Antiseptic Description and Business Overview
6.21.3 Sirmaxo Chemicals Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Sirmaxo Chemicals Surgical Skin Antiseptic Product Portfolio
6.21.5 Sirmaxo Chemicals Recent Developments/Updates
6.22 Kimberly-Clark
6.22.1 Kimberly-Clark Corporation Information
6.22.2 Kimberly-Clark Surgical Skin Antiseptic Description and Business Overview
6.22.3 Kimberly-Clark Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Kimberly-Clark Surgical Skin Antiseptic Product Portfolio
6.22.5 Kimberly-Clark Recent Developments/Updates
6.23 Microgen
6.23.1 Microgen Corporation Information
6.23.2 Microgen Surgical Skin Antiseptic Description and Business Overview
6.23.3 Microgen Surgical Skin Antiseptic Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Microgen Surgical Skin Antiseptic Product Portfolio
6.23.5 Microgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Surgical Skin Antiseptic Industry Chain Analysis
7.2 Surgical Skin Antiseptic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Surgical Skin Antiseptic Production Mode & Process
7.4 Surgical Skin Antiseptic Sales and Marketing
7.4.1 Surgical Skin Antiseptic Sales Channels
7.4.2 Surgical Skin Antiseptic Distributors
7.5 Surgical Skin Antiseptic Customers
8 Surgical Skin Antiseptic Market Dynamics
8.1 Surgical Skin Antiseptic Industry Trends
8.2 Surgical Skin Antiseptic Market Drivers
8.3 Surgical Skin Antiseptic Market Challenges
8.4 Surgical Skin Antiseptic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figure
List of Tables
Table 1. Global Surgical Skin Antiseptic Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Surgical Skin Antiseptic Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Surgical Skin Antiseptic Market Competitive Situation by Manufacturers in 2022
Table 4. Global Surgical Skin Antiseptic Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Surgical Skin Antiseptic Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Surgical Skin Antiseptic Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Surgical Skin Antiseptic Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Surgical Skin Antiseptic Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Surgical Skin Antiseptic, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Surgical Skin Antiseptic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Surgical Skin Antiseptic, Product Type & Application
Table 12. Global Key Manufacturers of Surgical Skin Antiseptic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Surgical Skin Antiseptic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Skin Antiseptic as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Surgical Skin Antiseptic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Surgical Skin Antiseptic Sales by Region (2018-2024) & (K Units)
Table 18. Global Surgical Skin Antiseptic Sales Market Share by Region (2018-2024)
Table 19. Global Surgical Skin Antiseptic Sales by Region (2024-2029) & (K Units)
Table 20. Global Surgical Skin Antiseptic Sales Market Share by Region (2024-2029)
Table 21. Global Surgical Skin Antiseptic Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Surgical Skin Antiseptic Revenue Market Share by Region (2018-2024)
Table 23. Global Surgical Skin Antiseptic Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Surgical Skin Antiseptic Revenue Market Share by Region (2024-2029)
Table 25. North America Surgical Skin Antiseptic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Surgical Skin Antiseptic Sales by Country (2018-2024) & (K Units)
Table 27. North America Surgical Skin Antiseptic Sales by Country (2024-2029) & (K Units)
Table 28. North America Surgical Skin Antiseptic Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Surgical Skin Antiseptic Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Surgical Skin Antiseptic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Surgical Skin Antiseptic Sales by Country (2018-2024) & (K Units)
Table 32. Europe Surgical Skin Antiseptic Sales by Country (2024-2029) & (K Units)
Table 33. Europe Surgical Skin Antiseptic Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Surgical Skin Antiseptic Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Surgical Skin Antiseptic Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Surgical Skin Antiseptic Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Surgical Skin Antiseptic Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Surgical Skin Antiseptic Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Surgical Skin Antiseptic Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Surgical Skin Antiseptic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Surgical Skin Antiseptic Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Surgical Skin Antiseptic Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Surgical Skin Antiseptic Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Surgical Skin Antiseptic Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Surgical Skin Antiseptic Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Surgical Skin Antiseptic Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Surgical Skin Antiseptic Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Surgical Skin Antiseptic Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Surgical Skin Antiseptic Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Surgical Skin Antiseptic Sales (K Units) by Type (2018-2024)
Table 51. Global Surgical Skin Antiseptic Sales (K Units) by Type (2024-2029)
Table 52. Global Surgical Skin Antiseptic Sales Market Share by Type (2018-2024)
Table 53. Global Surgical Skin Antiseptic Sales Market Share by Type (2024-2029)
Table 54. Global Surgical Skin Antiseptic Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Surgical Skin Antiseptic Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Surgical Skin Antiseptic Revenue Market Share by Type (2018-2024)
Table 57. Global Surgical Skin Antiseptic Revenue Market Share by Type (2024-2029)
Table 58. Global Surgical Skin Antiseptic Price (US$/Unit) by Type (2018-2024)
Table 59. Global Surgical Skin Antiseptic Price (US$/Unit) by Type (2024-2029)
Table 60. Global Surgical Skin Antiseptic Sales (K Units) by Application (2018-2024)
Table 61. Global Surgical Skin Antiseptic Sales (K Units) by Application (2024-2029)
Table 62. Global Surgical Skin Antiseptic Sales Market Share by Application (2018-2024)
Table 63. Global Surgical Skin Antiseptic Sales Market Share by Application (2024-2029)
Table 64. Global Surgical Skin Antiseptic Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Surgical Skin Antiseptic Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Surgical Skin Antiseptic Revenue Market Share by Application (2018-2024)
Table 67. Global Surgical Skin Antiseptic Revenue Market Share by Application (2024-2029)
Table 68. Global Surgical Skin Antiseptic Price (US$/Unit) by Application (2018-2024)
Table 69. Global Surgical Skin Antiseptic Price (US$/Unit) by Application (2024-2029)
Table 70. 3M Corporation Information
Table 71. 3M Description and Business Overview
Table 72. 3M Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. 3M Surgical Skin Antiseptic Product
Table 74. 3M Recent Developments/Updates
Table 75. BD Corporation Information
Table 76. BD Description and Business Overview
Table 77. BD Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. BD Surgical Skin Antiseptic Product
Table 79. BD Recent Developments/Updates
Table 80. EcoLab Corporation Information
Table 81. EcoLab Description and Business Overview
Table 82. EcoLab Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. EcoLab Surgical Skin Antiseptic Product
Table 84. EcoLab Recent Developments/Updates
Table 85. Medtronic Corporation Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Medtronic Surgical Skin Antiseptic Product
Table 89. Medtronic Recent Developments/Updates
Table 90. Cardinal Health Corporation Information
Table 91. Cardinal Health Description and Business Overview
Table 92. Cardinal Health Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Cardinal Health Surgical Skin Antiseptic Product
Table 94. Cardinal Health Recent Developments/Updates
Table 95. Schülke & Mayr GmbH Corporation Information
Table 96. Schülke & Mayr GmbH Description and Business Overview
Table 97. Schülke & Mayr GmbH Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Schülke & Mayr GmbH Surgical Skin Antiseptic Product
Table 99. Schülke & Mayr GmbH Recent Developments/Updates
Table 100. Purdue Pharma Corporation Information
Table 101. Purdue Pharma Description and Business Overview
Table 102. Purdue Pharma Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Purdue Pharma Surgical Skin Antiseptic Product
Table 104. Purdue Pharma Recent Developments/Updates
Table 105. CVS Health Corporation Information
Table 106. CVS Health Description and Business Overview
Table 107. CVS Health Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. CVS Health Surgical Skin Antiseptic Product
Table 109. CVS Health Recent Developments/Updates
Table 110. B. Braun Melsungen Corporation Information
Table 111. B. Braun Melsungen Description and Business Overview
Table 112. B. Braun Melsungen Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. B. Braun Melsungen Surgical Skin Antiseptic Product
Table 114. B. Braun Melsungen Recent Developments/Updates
Table 115. McKesson Corp Corporation Information
Table 116. McKesson Corp Description and Business Overview
Table 117. McKesson Corp Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. McKesson Corp Surgical Skin Antiseptic Product
Table 119. McKesson Corp Recent Developments/Updates
Table 120. Stryker Corporation Information
Table 121. Stryker Description and Business Overview
Table 122. Stryker Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Stryker Surgical Skin Antiseptic Product
Table 124. Stryker Recent Developments/Updates
Table 125. PSK Pharma Corporation Information
Table 126. PSK Pharma Description and Business Overview
Table 127. PSK Pharma Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. PSK Pharma Surgical Skin Antiseptic Product
Table 129. PSK Pharma Recent Developments/Updates
Table 130. Mölnlycke Corporation Information
Table 131. Mölnlycke Description and Business Overview
Table 132. Mölnlycke Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Mölnlycke Surgical Skin Antiseptic Product
Table 134. Mölnlycke Recent Developments/Updates
Table 135. MPM Medical Corporation Information
Table 136. MPM Medical Description and Business Overview
Table 137. MPM Medical Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. MPM Medical Surgical Skin Antiseptic Product
Table 139. MPM Medical Recent Developments/Updates
Table 140. Vesismin Health Corporation Information
Table 141. Vesismin Health Description and Business Overview
Table 142. Vesismin Health Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Vesismin Health Surgical Skin Antiseptic Product
Table 144. Vesismin Health Recent Developments/Updates
Table 145. AmerisourceBergen Corporation Information
Table 146. AmerisourceBergen Description and Business Overview
Table 147. AmerisourceBergen Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. AmerisourceBergen Surgical Skin Antiseptic Product
Table 149. AmerisourceBergen Recent Developments/Updates
Table 150. Cigna Corporation Information
Table 151. Cigna Description and Business Overview
Table 152. Cigna Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Cigna Surgical Skin Antiseptic Product
Table 154. Cigna Recent Developments/Updates
Table 155. Medline Industries Corporation Information
Table 156. Medline Industries Description and Business Overview
Table 157. Medline Industries Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Medline Industries Surgical Skin Antiseptic Product
Table 159. Medline Industries Recent Developments/Updates
Table 160. Abbott Corporation Information
Table 161. Abbott Description and Business Overview
Table 162. Abbott Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Abbott Surgical Skin Antiseptic Product
Table 164. Abbott Recent Developments/Updates
Table 165. Baxter Corporation Information
Table 166. Baxter Description and Business Overview
Table 167. Baxter Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Baxter Surgical Skin Antiseptic Product
Table 169. Baxter Recent Developments/Updates
Table 170. Sirmaxo Chemicals Corporation Information
Table 171. Sirmaxo Chemicals Description and Business Overview
Table 172. Sirmaxo Chemicals Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Sirmaxo Chemicals Surgical Skin Antiseptic Product
Table 174. Sirmaxo Chemicals Recent Developments/Updates
Table 175. Kimberly-Clark Corporation Information
Table 176. Kimberly-Clark Description and Business Overview
Table 177. Kimberly-Clark Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Kimberly-Clark Surgical Skin Antiseptic Product
Table 179. Kimberly-Clark Recent Developments/Updates
Table 180. Microgen Corporation Information
Table 181. Microgen Description and Business Overview
Table 182. Microgen Surgical Skin Antiseptic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Microgen Surgical Skin Antiseptic Product
Table 184. Microgen Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Surgical Skin Antiseptic Distributors List
Table 188. Surgical Skin Antiseptic Customers List
Table 189. Surgical Skin Antiseptic Market Trends
Table 190. Surgical Skin Antiseptic Market Drivers
Table 191. Surgical Skin Antiseptic Market Challenges
Table 192. Surgical Skin Antiseptic Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Surgical Skin Antiseptic
Figure 2. Global Surgical Skin Antiseptic Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Surgical Skin Antiseptic Market Share by Type in 2022 & 2029
Figure 4. Alcohols Product Picture
Figure 5. Chlorhexidine Product Picture
Figure 6. Iodine Product Picture
Figure 7. Octenidine Product Picture
Figure 8. Others Product Picture
Figure 9. Global Surgical Skin Antiseptic Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Surgical Skin Antiseptic Market Share by Application in 2022 & 2029
Figure 11. Surgeries
Figure 12. Injections
Figure 13. Others
Figure 14. Global Surgical Skin Antiseptic Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Surgical Skin Antiseptic Market Size (2018-2029) & (US$ Million)
Figure 16. Global Surgical Skin Antiseptic Sales (2018-2029) & (K Units)
Figure 17. Global Surgical Skin Antiseptic Average Price (US$/Unit) & (2018-2029)
Figure 18. Surgical Skin Antiseptic Report Years Considered
Figure 19. Surgical Skin Antiseptic Sales Share by Manufacturers in 2022
Figure 20. Global Surgical Skin Antiseptic Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Surgical Skin Antiseptic Players: Market Share by Revenue in 2022
Figure 22. Surgical Skin Antiseptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Surgical Skin Antiseptic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Surgical Skin Antiseptic Sales Market Share by Country (2018-2029)
Figure 25. North America Surgical Skin Antiseptic Revenue Market Share by Country (2018-2029)
Figure 26. United States Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Surgical Skin Antiseptic Sales Market Share by Country (2018-2029)
Figure 29. Europe Surgical Skin Antiseptic Revenue Market Share by Country (2018-2029)
Figure 30. Germany Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Surgical Skin Antiseptic Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Surgical Skin Antiseptic Revenue Market Share by Region (2018-2029)
Figure 37. China Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Surgical Skin Antiseptic Sales Market Share by Country (2018-2029)
Figure 47. Latin America Surgical Skin Antiseptic Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Surgical Skin Antiseptic Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Surgical Skin Antiseptic Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Surgical Skin Antiseptic Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Surgical Skin Antiseptic by Type (2018-2029)
Figure 57. Global Revenue Market Share of Surgical Skin Antiseptic by Type (2018-2029)
Figure 58. Global Surgical Skin Antiseptic Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Surgical Skin Antiseptic by Application (2018-2029)
Figure 60. Global Revenue Market Share of Surgical Skin Antiseptic by Application (2018-2029)
Figure 61. Global Surgical Skin Antiseptic Price (US$/Unit) by Application (2018-2029)
Figure 62. Surgical Skin Antiseptic Value Chain
Figure 63. Surgical Skin Antiseptic Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed